The main challenge for the practical deployment of cell-free massive multi-input-multi-output (CF-mMIMO) systems under imperfect channel state information (CSI) is the high hardware cost caused by ...

Van Andel Institute scientists have developed an improved technique to comprehensively profile DNA methylation in single cells, an advance that will help researchers better study the role of ...

Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative.

Keywords: circulating cell-free DNA, circulating tumor DNA, obstructive colon cancer, self-expanding metallic stent (SEMS), neoadjuvant chemotherapy Citation: Zhang K, Han J and Zhai Z (2025) ...

Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden and endotoxin risks.

Effective power control is key to solving the inter-user interference problem that degrades performance in cell-free massive multiple-input multiple-output (MIMO) systems. Motivated by its ability to ...

AbstractTo explore how early cancers can be detected prior to clinical signs or symptoms, we assessed prospectively collected serial plasma samples from the Atherosclerosis Risk in Communities study, ...